TALKSPACE, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 80 rows, 80 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2025-12-01: Reporting owner Margolin Gil; Form 4; Security Stock Options; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2025-09-02: Reporting owner Margolin Gil; Form 4; Security Stock Options; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2025-06-10: Reporting owner Harris Ian Jiro; Form 4; Security Stock Options; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2025-06-02: Reporting owner Margolin Gil; Form 4; Security Stock Options; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-12-01 | Margolin Gil Officer (Chief Technology Officer) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,516 0 owned after | $0.88 exercise price | 2025-12-02 | |
| 2025-09-02 | Margolin Gil Officer (Chief Technology Officer) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +3,516 3,516 owned after | $0.88 exercise price | 2025-09-03 | |
| 2025-06-10 | Harris Ian Jiro Officer (Chief Financial Officer) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,380 65,702 owned after | $2.86 exercise price | 2025-06-12 | |
| 2025-06-02 | Margolin Gil Officer (Chief Technology Officer) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,516 7,032 owned after | $0.88 exercise price | 2025-06-05 | |
| 2025-03-04 | Reilly John Charles Officer (Chief Legal Officer, Secretary) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,000 38,851 owned after | $1.61 exercise price | 2025-03-04 | |
| 2025-03-04 | Reilly John Charles Officer (Chief Legal Officer, Secretary) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −13,625 59,044 owned after | $0.88 exercise price | 2025-03-04 | |
| 2025-03-01 | Reilly John Charles Officer (Chief Legal Officer, Secretary) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +48,518 48,518 owned after | $2.86 exercise price | 2025-03-04 | |
| 2025-03-01 | Harris Ian Jiro Officer (Chief Financial Officer) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +70,082 70,082 owned after | $2.86 exercise price | 2025-03-04 | |
| 2025-03-01 | Margolin Gil Officer (Chief Technology Officer) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,877 25,877 owned after | $2.86 exercise price | 2025-03-04 | |
| 2025-03-01 | Watson Katelyn Officer (Chief Marketing Officer) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,869 18,869 owned after | $2.86 exercise price | 2025-03-04 | |
| 2025-03-01 | Cohen Jon R Director, Officer (Chief Executive Officer) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +539,088 539,088 owned after | $2.86 exercise price | 2025-03-04 | |
| 2024-11-20 | Margolin Gil Officer (Chief Technology Officer) | 4 | Employee Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −85,022 0 owned after | $1.22 exercise price | 2024-11-22 | |
| 2024-11-20 | Margolin Gil Officer (Chief Technology Officer) | 4 | Employee Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −28,475 17,088 owned after | $1.61 exercise price | 2024-11-22 | |
| 2024-11-20 | Margolin Gil Officer (Chief Technology Officer) | 4 | Employee Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −21,097 35,163 owned after | $0.88 exercise price | 2024-11-22 | |
| 2024-06-26 holding as of filing | Watson Katelyn Officer (Chief Marketing Officer) | 3 | Stock Option Derivative · Direct | Holding | $0.88 exercise price | 2024-06-26 | ||
| 2024-06-26 holding as of filing | Watson Katelyn Officer (Chief Marketing Officer) | 3 | Stock Option Derivative · Direct | Holding | $2.99 exercise price | 2024-06-26 | ||
| 2024-04-24 | Dziedzic Steven Officer (Chief Product Officer) | 4 | Employee Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,574 34,723 owned after | $0.88 exercise price | 2024-04-26 | |
| 2024-03-19 | Reilly John Charles Officer (CLO, EVP Gov Relat & Secretary) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −18,167 54,502 owned after | $0.88 exercise price | 2024-03-20 | |
| 2024-03-19 | Reilly John Charles Officer (CLO, EVP Gov Relat & Secretary) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,716 5,907 owned after | $1.22 exercise price | 2024-03-20 | |
| 2024-03-01 | Reilly John Charles Officer (General Counsel and Secretary) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +51,373 51,373 owned after | $1.75 exercise price | 2024-03-08 | |
| 2024-03-01 | Cohen Jon R Director, Officer (Chief Executive Officer) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +214,051 1,414,262 owned after | $1.75 exercise price | 2024-03-05 | |
| 2024-03-01 | Dziedzic Steven Officer (Chief Product Officer) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,687 71,984 owned after | $1.75 exercise price | 2024-03-05 | |
| 2024-03-01 | Fulk Jennifer Officer (Chief Financial Officer) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +74,205 245,219 owned after | $1.75 exercise price | 2024-03-05 | |
| 2023-12-01 | Abbott Swati Bargotra Director | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +57,985 57,985 owned after | $1.29 exercise price | 2023-12-07 | |
| 2023-12-01 | Benzur Liat Director | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +57,985 57,985 owned after | $1.29 exercise price | 2023-12-07 | |
| 2023-06-23 holding as of filing | Dziedzic Steven Officer (Chief Product Officer) | 3 | Stock Option Derivative · Direct | Holding | $7.24 exercise price | 2023-06-23 | ||
| 2023-03-01 | Reilly John Charles Officer (General Counsel and Secretary) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +72,669 72,699 owned after | $0.88 exercise price | 2024-03-08 | |
| 2023-03-01 | Fulk Jennifer Officer (Chief Financial Officer) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +47,616 171,014 owned after | $0.88 exercise price | 2024-03-05 | |
| 2023-03-01 | Dziedzic Steven Officer (Chief Product Officer) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +46,297 46,297 owned after | $0.88 exercise price | 2023-06-23 | |
| 2022-12-01 | Cohen Jon R Director, Officer (Chief Executive Officer) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +500,000 700,211 owned after | $0.86 exercise price | 2024-03-05 | |
| 2022-12-01 | Cohen Jon R Director, Officer (Chief Executive Officer) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +400,000 1,100,211 owned after | $0.86 exercise price | 2024-03-05 | |
| 2022-09-26 | Hansen Michael E Director | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,211 200,211 owned after | $1.00 exercise price | 2022-09-28 | |
| 2022-09-26 | Cohen Jon R Director | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,211 200,211 owned after | $1.00 exercise price | 2022-09-28 | |
| 2022-05-09 | Braunstein Douglas L Director, Officer (See Remarks), 10% Owner | 4 | Employee Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +640,000 640,000 owned after | $1.22 exercise price | 2022-05-11 | |
| 2022-03-08 | Margolin Gil Officer (Chief Technology Officer) | 4 | Employee Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −253,094 0 owned after | $0.39 exercise price | 2022-03-10 | |
| 2022-03-08 | Margolin Gil Officer (Chief Technology Officer) | 4 | Employee Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −236,356 287,419 owned after | $0.51 exercise price | 2022-03-10 | |
| 2022-03-01 | Boyd Erin Officer (Chief Growth Officer) | 4 | Employee Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +45,563 45,563 owned after | $1.61 exercise price | 2022-06-10 | |
| 2022-03-01 | Reilly John Charles Officer (General Counsel and Secretary) | 4 | Employee Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +58,851 58,851 owned after | $1.61 exercise price | 2022-03-03 | |
| 2022-03-01 | Margolin Gil Officer (Chief Technology Officer) | 4 | Employee Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +45,563 45,563 owned after | $1.61 exercise price | 2022-03-03 | |
| 2022-03-01 | Fulk Jennifer Officer (Chief Financial Officer) | 4 | Employee Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +123,398 123,398 owned after | $1.61 exercise price | 2022-03-03 | |
| 2022-03-01 | Braunstein Samara H. Officer (Chief Marketing Officer) | 4 | Employee Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +43,664 43,664 owned after | $1.61 exercise price | 2022-03-03 | |
| 2022-02-05 | Reilly John Charles Officer (General Counsel and Secretary) | 4 | Employee Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,083 36,623 owned after | $1.22 exercise price | 2022-03-03 | |
| 2022-02-04 | Reilly John Charles Officer (General Counsel and Secretary) | 4 | Employee Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −39,075 25,604 owned after | $1.21 exercise price | 2022-03-03 | |
| 2021-12-06 | Reilly John Charles Officer (General Counsel and Secretary) | 4 | Employee Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −67,792 0 owned after | $0.39 exercise price | 2021-12-08 | |
| 2021-10-26 | Crowe Jeffrey Director | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +63,402 63,402 owned after | $8.52 exercise price | 2021-10-26 | |
| 2021-10-26 | Shachar Erez Director | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +63,402 63,402 owned after | $8.52 exercise price | 2021-10-26 | |
| 2021-10-18 | Boyd Erin Officer (Chief Growth Officer) | 4 | Employee Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $3.65 exercise price | 2022-06-10 | |
| 2021-07-26 | Fulk Jennifer Officer (Chief Financial Officer) | 4 | Employee Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +492,600 492,600 owned after | $6.36 exercise price | 2021-07-26 | |
| 2021-07-15 | Braunstein Samara H. Officer (Chief Marketing Officer) | 4 | Employee Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +495,000 495,000 owned after | $5.81 exercise price | 2021-10-20 | |
| 2021-07-15 | Margolin Gil Officer (Chief Technology Officer) | 4 | Employee Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +495,000 495,000 owned after | $5.81 exercise price | 2021-10-20 | |
| 2021-07-15 | Reilly John Charles Officer (General Counsel and Secretary) | 4 | Employee Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +247,500 247,500 owned after | $5.81 exercise price | 2021-10-20 | |
| 2021-07-15 | HIRSCHHORN MARK Officer (President and COO) | 4 | Employee Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +990,000 990,000 owned after | $5.81 exercise price | 2021-10-20 | |
| 2021-07-15 | Frank Roni Director, Officer (Head of Clinical Services) | 4 | Employee Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +495,000 495,000 owned after | $5.81 exercise price | 2021-10-20 | |
| 2021-07-15 | Frank Oren Director, Officer (Chief Executive Officer) | 4 | Employee Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,732,500 1,732,500 owned after | $5.81 exercise price | 2021-10-20 | |
| 2021-06-22 | Pawar Madhu Director | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +63,402 63,402 owned after | $8.52 exercise price | 2021-06-24 | |
| 2021-06-22 | Frank Oren Director, Officer (CEO) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +226,827 226,827 owned after | $1.22 exercise price | 2021-06-24 | |
| 2021-06-22 | Frank Oren Director, Officer (CEO) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +571,810 571,810 owned after | $0.39 exercise price | 2021-06-24 | |
| 2021-06-22 | Frank Oren Director, Officer (CEO) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +628,399 628,399 owned after | $0.23 exercise price | 2021-06-24 | |
| 2021-06-22 | Frank Oren Director, Officer (CEO) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +646,802 646,802 owned after | $1.21 exercise price | 2021-06-24 | |
| 2021-06-22 | Frank Oren Director, Officer (CEO) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +834,144 834,144 owned after | $0.51 exercise price | 2021-06-24 | |
| 2021-06-22 | Margolin Gil Officer (Chief Technology Officer) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +113,413 113,413 owned after | $1.22 exercise price | 2021-06-24 | |
| 2021-06-22 | Margolin Gil Officer (Chief Technology Officer) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +323,400 323,400 owned after | $1.21 exercise price | 2021-06-24 | |
| 2021-06-22 | Margolin Gil Officer (Chief Technology Officer) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +523,775 523,775 owned after | $0.51 exercise price | 2021-06-24 | |
| 2021-06-22 | Margolin Gil Officer (Chief Technology Officer) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +253,094 253,094 owned after | $0.39 exercise price | 2021-06-24 | |
| 2021-06-22 | Margolin Gil Officer (Chief Technology Officer) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +656,990 656,990 owned after | $0.10 exercise price | 2021-06-24 | |
| 2021-06-22 | Braunstein Samara H. Officer (Chief Marketing Officer) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +508,551 508,551 owned after | $7.24 exercise price | 2021-06-24 | |
| 2021-06-22 | Frank Roni Director, Officer (Head of Clinical Services) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +226,827 226,827 owned after | $1.22 exercise price | 2021-06-24 | |
| 2021-06-22 | Frank Roni Director, Officer (Head of Clinical Services) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +834,144 834,144 owned after | $0.51 exercise price | 2021-06-24 | |
| 2021-06-22 | Frank Roni Director, Officer (Head of Clinical Services) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +628,399 628,399 owned after | $0.23 exercise price | 2021-06-24 | |
| 2021-06-22 | Frank Roni Director, Officer (Head of Clinical Services) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +646,802 646,802 owned after | $1.21 exercise price | 2021-06-24 | |
| 2021-06-22 | Frank Roni Director, Officer (Head of Clinical Services) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +571,810 571,810 owned after | $0.39 exercise price | 2021-06-24 | |
| 2021-06-22 | BERG CHARLES Director | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +63,402 63,402 owned after | $8.52 exercise price | 2021-06-24 | |
| 2021-06-22 | Braunstein Douglas L Director | 4 | Stock Options Derivative · Direct · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +63,402 63,402 owned after | $8.52 exercise price | 2021-06-24 | |
| 2021-06-22 | HIRSCHHORN MARK Officer (President, COO and CFO) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +646,800 646,800 owned after | $1.21 exercise price | 2021-06-24 | |
| 2021-06-22 | HIRSCHHORN MARK Officer (President, COO and CFO) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,730,408 1,730,408 owned after | $1.21 exercise price | 2021-06-24 | |
| 2021-06-22 | Warfield Curtis Director | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +63,402 63,402 owned after | $8.52 exercise price | 2021-06-24 | |
| 2021-06-22 | Reilly John Charles Officer (General Counsel and Secretary) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +56,706 56,706 owned after | $1.22 exercise price | 2021-06-24 | |
| 2021-06-22 | Reilly John Charles Officer (General Counsel and Secretary) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +64,679 64,679 owned after | $1.21 exercise price | 2021-06-24 | |
| 2021-06-22 | Reilly John Charles Officer (General Counsel and Secretary) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +67,792 67,792 owned after | $0.39 exercise price | 2021-06-24 | |
| 2021-06-22 | YEANEY JACQUELINE E Director | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +63,402 63,402 owned after | $8.52 exercise price | 2021-06-24 |